{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiepbceoimlo4rp4ttbwwgrmqlijjtdgsaqoiqr3hn7ha7rkurx22i",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mpjh4klzltv2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiccksumxaqmlay7rvfact3mnkegctscj6vmxzrff2zh3jl75ajiwm"
    },
    "mimeType": "image/jpeg",
    "size": 162489
  },
  "path": "/news/2026-06-ai-pathology-analysis-immunotherapy-response.html",
  "publishedAt": "2026-06-30T12:40:09.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based analysis of tumor biopsies can predict responses to immunotherapy in a study of patients with rare cancers, published in the Journal for ImmunoTherapy of Cancer.",
  "title": "AI-guided pathology analysis can help predict immunotherapy response in rare cancers"
}